Other languages Nevro Corp.

Equities

NVRO

US64157F1030

Market Closed - Nyse Other stock markets 01:30:01 27/04/2024 am IST			5-day change	1st Jan Change
11.32 ^USD	-2.58%		-6.21%	-47.40%

15/04	RBC Lowers Price Target on Nevro to $16 From $18, Keeps Sector Perform Rating	MT
11/04	Mizuho Adjusts Price Target on Nevro to $16 From $20, Maintains Neutral Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nevro 2024 Sales Expected Slightly Below Estimates, RBC Says	23/02
Nevro Corp. Appoints Kirt P. Karros to Board of Directors and Audit Committee of the Board	22/02
Nevro Corp. Provides Earnings Guidance for the First Quarter and Full Year of 2024	22/02
Nevro Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22/02
Sector Update: Health Care Stocks Mixed in Afternoon Trading	10/01
Nevro to Cut 5% of Workforce in Restructuring, Says Preliminary Q4 Revenue Rose 2%	09/01
Nevro Acquires Vyrsa Technologies, Closes Term Loan Credit Facility; Shares Rise After Hours	01/12
Nevro Corp. acquired Vyrsa Technologies for $75 million.	30/11
Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain	20/11
Nevro Corp. Provides Revenue Guidance for the Fourth Quarter of 2023	02/11
Nevro Corp. Increases Revenue Guidance for the Full-Year 2023	02/11
Nevro Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02/11
Nevro Corp. Announces New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy	16/23/16
Nevro Announces Launch of HFX Connect in Europe and CE Marking of Expanded Labelling for the HFX SCS system	10/23/10
Nevro Corp. Revises Earnings Guidance for the Full-Year 2023	02/23/02
Nevro Corp. Provides Revenue Guidance for the Third Quarter of 2023	02/23/02
Nevro Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	02/23/02
Insider Buy: Nevro	10/23/10
Nevro Appoints Greg Siller as Chief Commercial Officer; Lowers Q2 Revenue Guidance	06/23/06
Nevro Corp. Announces Executive Changes	06/23/06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Nevro Corp.

Equities

NVRO

US64157F1030

Other languages

Filters